Dr. Didier Merlin
Digestive Diseases at Emory University School
Biography & Research Background
Didier Merlin, PhD, is affiliated with the Department of Medicine, Division of Digestive Diseases at Emory University School of Medicine, and the Institute for Biomedical Sciences at Georgia State University. Dr. Merlin's research established PepT1-mediated uptake as the primary mechanism of KPV action in intestinal inflammation. His group developed hyaluronic acid-functionalized nanoparticles (HA-KPV-NPs) that achieved a 12,000-fold potency increase in targeted colonic delivery for ulcerative colitis treatment. Didier Merlin is being referenced as one of the leading scientists involved in the research and development of KPV. In no way is this doctor/scientist endorsing or advocating the purchase, sale, or use of this product for any reason. There is no affiliation or relationship, implied or otherwise, between Pure US Peptide and this doctor.
External Profiles
Authored Research Profiles (1)
Dr. Didier Merlin is referenced as a leading researcher in the following peptide research profiles on Pure U.S. Peptides:
Dr. Didier Merlin is being referenced as one of the leading scientists involved in the research and development of the peptides listed above. In no way is this doctor/scientist endorsing or advocating the purchase, sale, or use of any product for any reason. There is no affiliation or relationship, implied or otherwise, between Pure U.S. Peptides and this researcher. The purpose of citing the researcher is to acknowledge, recognize, and credit the exhaustive research and development efforts conducted by the scientists studying these peptides.